Co-occurring genomic alterations in non-small-cell lung cancer

Common genomic alterations recommended for inclusion in a

Frontiers State-of-the-art combination treatment strategies for

Joint inference of exclusivity patterns and recurrent trajectories from tumor mutation trees

Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesis

PDF) Mutational Landscape and Expression of PD-L1 in Patients with

Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes

IJMS, Free Full-Text

Molecular Diagnostic and Precision Medicine in Non-Small Cell

IJMS, Free Full-Text

Cancers, Free Full-Text